WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007010533) MUCOSAL OR ENTERAL ADMINISTRATION OF BIOLOGICALLY ACTIVE MACROMOLECULES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/010533    International Application No.:    PCT/IL2006/000832
Publication Date: 25.01.2007 International Filing Date: 18.07.2006
Chapter 2 Demand Filed:    15.05.2007    
IPC:
C12N 15/82 (2006.01)
Applicants: PROTALIX LTD. [IL/IL]; 2 Snunit Street, Science Park, 20100 Carmiel (IL) (For All Designated States Except US).
SHAALTIEL, Yoseph [IL/IL]; (IL) (For US Only).
ALMON, Einat [IL/IL]; (IL) (For US Only)
Inventors: SHAALTIEL, Yoseph; (IL).
ALMON, Einat; (IL)
Agent: G.E. EHRLICH (1995) LTD.; 11 Menachem Begin Street, 52521 Ramat Gan (IL)
Priority Data:
60/699,928 18.07.2005 US
Title (EN) MUCOSAL OR ENTERAL ADMINISTRATION OF BIOLOGICALLY ACTIVE MACROMOLECULES
(FR) ADMINISTRATION MUCOSALE OU ENTERALE DE MACROMOLECULES BIOLOGIQUEMENT ACTIVES
Abstract: front page image
(EN)A method of systemically delivering a biologically active, recombinant biomolecule, in a biologically active form, to a subject in need thereof, the method comprising, enterally or mucosally administering to the subject a therapeutically effective amount of plant cells expressing an exogenous biologically active recombinant biomolecule, thereby systemically delivering the biologically active recombinant biomolecule, in a biologically active form, to the subject.
(FR)Cette invention concerne une méthode d'administration systémique d'une biomolécule recombinante biologiquement active, dans une forme biologiquement active, à un sujet nécessitant un tel traitement, laquelle méthode consiste à administrer au sujet par voie entérale ou mucosale une quantité thérapeutiquement efficace de cellules végétales exprimant une biomolécule recombinante biologiquement active exogène, ce qui permet d'administrer au sujet de manière systémique la biomolécule de recombinaison biologiquement active, dans une forme biologiquement active.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)